Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 21 | 6 | 6 | 6 |
| Inventories | N/A | N/A | 83 | 83 | 159 |
| TOTAL | $7 | $21 | $89 | $89 | $165 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 3 | 3 |
| TOTAL | $2 | $2 | $3 | $3 | $3 |
| Total Assets | $8 | $24 | $91 | $92 | $168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,275 | 2,148 | 2,022 | 2,328 | 1,556 |
| Accrued Expenses | 4,235 | 3,915 | 3,606 | 3,040 | 3,088 |
| Other current liabilities | 1,336 | 909 | 739 | 787 | 1,449 |
| TOTAL | $13,479 | $12,553 | $11,846 | $11,342 | $10,887 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,479 | $12,553 | $11,846 | $11,342 | $10,887 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 0 | 446 | 446 | 456 | 434 |
| Common Shares | 0 | 46 | 46 | 0 | 42 |
| Retained earnings | -383,686 | -382,745 | -389,920 | -381,210 | -380,267 |
| Other shareholders' equity | 35 | 35 | 8,035 | 35 | 78 |
| TOTAL | $-13,471 | $-12,529 | $-11,755 | $-11,251 | $-10,720 |
| Total Liabilities And Equity | $8 | $24 | $91 | $92 | $168 |